Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-09 Purchase | 2024-09-11 5:47 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 140,000 | $2.8222 | $395,115 | 384,024 (Direct) | View |
| 2024-09-09 Purchase | 2024-09-11 5:47 pm | RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director | 13,000 | $2.56 | $33,280 | 13,000 (Direct) | View |
| 2024-09-09 Purchase | 2024-09-11 5:46 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 53,432 | $2.8017 | $149,701 | 88,335 (Direct) | View |
| 2024-09-09 Purchase | 2024-09-11 5:46 pm | RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director | 25,000 | $2.59 | $64,750 | 212,295 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 6:29 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 100,000 | $3.8674 | $386,738 | 244,024 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 6:28 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 32,675 | $3.8475 | $125,717 | 34,903 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 6:28 pm | RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO | 38,970 | $3.8727 | $150,920 | 38,970 (Direct) | View |
| 2023-05-23 Purchase | 2023-05-24 09:00 am | RELMADA THERAPEUTICS INC. | RLMD | O'Gorman Cedric Chief Medical Officer | 10,000 | $3.18 | $31,800 | 10,121 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-22 Gift | 2024-10-23 4:27 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director | 13,000 | $0 | 0 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:25 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 122,358 | $0 | 490,120 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:25 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 122,358 | $0 | 490,120 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 54,624 | $0 | 218,804 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 54,624 | $0 | 218,804 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director | 43,700 | $0 | 175,044 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director | 43,700 | $0 | 175,044 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director | 20,976 | $0 | 84,020 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director | 20,976 | $0 | 84,020 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director | 20,976 | $0 | 84,020 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director | 20,976 | $0 | 84,020 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:23 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO | 54,624 | $0 | 218,804 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:23 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO | 54,624 | $0 | 218,804 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:23 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director | 20,976 | $0 | 84,020 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:23 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director | 20,976 | $0 | 84,020 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:28 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 183,881 | $0 | 183,881 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:28 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 82,090 | $0 | 82,090 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:28 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director | 65,672 | $0 | 65,672 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:27 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director | 31,522 | $0 | 31,522 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:27 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director | 31,522 | $0 | 31,522 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:27 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck Chief Accounting and CO | 82,090 | $0 | 82,090 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:26 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director | 31,522 | $0 | 31,522 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:10 pm | 2022-12-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 527,211 | $0 | 850,728 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:09 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 317,643 | $0 | 512,560 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:09 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 92,958 | $0 | 150,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:08 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director | 92,958 | $0 | 150,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:08 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director | 92,958 | $0 | 150,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:06 pm | 2024-01-12 2033-01-12 | RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:06 pm | 2022-12-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO | 321,238 | $0 | 518,361 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:05 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director | 92,958 | $0 | 150,000 (Direct) | View |
| 2021-07-08 Ownership(A) | 2023-02-06 5:39 pm | N/A 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 351,985 | $0 | 777,934 (Direct) | View |
| 2021-07-08 Ownership | 2023-02-02 5:01 pm | N/A 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 351,985 | $0 | 552,934 (Direct) | View |
| 2021-07-08 Ownership | 2023-02-02 5:00 pm | N/A 2025-11-12 | RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director | 100,000 | $0 | 356,441 (Direct) | View |
| 2021-12-03 Ownership | 2023-02-02 5:00 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-13 5:54 pm | N/A 2033-01-06 | RELMADA THERAPEUTICS INC. | RLMD | O'Gorman Cedric Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2023-01-13 5:54 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | O'Gorman Cedric Chief Medical Officer | 0 | $0 | 121 (Direct) | View |
| 2022-12-16 Other | 2022-12-20 7:31 pm | N/A 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 300,000 | $0 | 0 (Direct) | View |
| 2022-12-16 Other | 2022-12-20 7:31 pm | N/A 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 200,000 | $0 | 0 (Direct) | View |